Mwi Veterinary Supply Inc (MWIV) Financial Statements (2024 and earlier)
Company Profile
Business Address |
3041 W. PASADENA DR. BOISE, ID 83705 |
State of Incorp. | DE |
Fiscal Year End | September 30 |
Industry (SIC) | 5047 - Medical, Dental, and Hospital Equipment and Supplies (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
9/30/2014 | 9/30/2013 | |||
---|---|---|---|---|
ASSETS | ||||
Current Assets | ||||
Cash, cash equivalents, and short-term investments | 1 | |||
Cash and cash equivalents | 1 | |||
Receivables | 307 | |||
Inventory, net of allowances, customer advances and progress billings | 326 | |||
Inventory | 326 | |||
Other undisclosed current assets | 8 | |||
Total current assets: | 643 | |||
Noncurrent Assets | ||||
Property, plant and equipment | 39 | |||
Long-term investments and receivables | ||||
Long-term investments | ||||
Intangible assets, net (including goodwill) | 112 | |||
Goodwill | 71 | |||
Intangible assets, net (excluding goodwill) | 40 | |||
Other noncurrent assets | 9 | |||
Other undisclosed noncurrent assets | ||||
Total noncurrent assets: | 160 | |||
TOTAL ASSETS: | 803 | |||
LIABILITIES AND EQUITY | ||||
Liabilities | ||||
Current Liabilities | ||||
Accounts payable and accrued liabilities | 346 | |||
Accounts payable | 324 | |||
Accrued liabilities | 22 | |||
Debt | 19 | |||
Total current liabilities: | 365 | |||
Noncurrent Liabilities | ||||
Long-term debt and lease obligation | 0 | |||
Capital lease obligations | 0 | |||
Liabilities, other than long-term debt | 11 | |||
Deferred tax liabilities, net | 9 | |||
Other liabilities | 2 | |||
Total noncurrent liabilities: | 11 | |||
Total liabilities: | 376 | |||
Equity | ||||
Equity, attributable to parent | 426 | |||
Common stock | 0 | |||
Additional paid in capital | 148 | |||
Accumulated other comprehensive income | 2 | |||
Retained earnings | 276 | |||
Total equity: | 426 | |||
TOTAL LIABILITIES AND EQUITY: | 803 |
Income Statement (P&L) ($ in millions)
9/30/2014 | 9/30/2013 | ||
---|---|---|---|
Revenues | 2,347 | ||
Revenue, net | 2,329 | ||
Cost of revenue (Cost of Goods and Services Sold) | (2,043) | ||
Gross profit: | 304 | ||
Operating expenses | (204) | ||
Other undisclosed operating income (loss) | 0 | ||
Operating income: | 100 | ||
Nonoperating income (expense) | 0 | ||
Other nonoperating income | 1 | ||
Interest and debt expense | (1) | ||
Income from continuing operations before equity method investments, income taxes: | 100 | ||
Income from equity method investments | 0 | ||
Income from continuing operations before income taxes: | 100 | ||
Income tax expense | (38) | ||
Income from continuing operations: | 62 | ||
Income before gain (loss) on sale of properties: | 62 | ||
Other undisclosed net income | 0 | ||
Net income available to common stockholders, diluted: | 63 |
Comprehensive Income ($ in millions)
9/30/2014 | 9/30/2013 | ||
---|---|---|---|
Net income: | 63 | ||
Other undisclosed comprehensive income (loss) | 0 | ||
Comprehensive income, net of tax, attributable to parent: | 63 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.